Publicaciones en colaboración con investigadores/as de Universitat de València (28)

2024

  1. Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia

    Scientific reports, Vol. 14, Núm. 1, pp. 12726

  2. Influence of Clinical Practice Guidelines on the Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis. Data from the Registry of the Spanish Society of Pulmonology and Thoracic Surgery

    Open Respiratory Archives, Vol. 6, Núm. 3

  3. Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease

    Archivos de Bronconeumologia, Vol. 60, Núm. 4, pp. 226-237

  4. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Is the long-term mortality similar in COVID-19 and community-acquired pneumonia?

    Frontiers in Medicine, Vol. 10

2022

  1. Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria

    Chest, Vol. 162, Núm. 4, pp. 768-781

2020

  1. Effect of antiviral treatment in older patients hospitalized with confirmed influenza

    Antiviral Research, Vol. 178

2018

  1. A Composite of Functional Status and Pneumonia Severity Index Improves the Prediction of Pneumonia Mortality in Older Patients

    Journal of General Internal Medicine, Vol. 33, Núm. 4, pp. 437-444

  2. Asthma and influenza vaccination in elderly hospitalized patients: Matched case-control study in Spain

    Journal of Asthma, Vol. 55, Núm. 4, pp. 391-401

  3. Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: A multicentre case-control study

    CMAJ, Vol. 190, Núm. 1, pp. E3-E12

  4. Smoking may increase the risk of influenza hospitalization and reduce influenza vaccine effectiveness in the elderly

    European Journal of Public Health, Vol. 28, Núm. 1, pp. 150-155

2017

  1. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study

    International Journal of Antimicrobial Agents, Vol. 50, Núm. 3, pp. 334-341

  2. Asthma in older people hospitalized with influenza in Spain: A case-control study

    Allergy and Asthma Proceedings, Vol. 38, Núm. 4, pp. 277-285

  3. Costs associated with influenza-related hospitalization in the elderly

    Human Vaccines and Immunotherapeutics, Vol. 13, Núm. 2, pp. 412-416

  4. Cystic fibrosis treatment: targeting the basic defect

    Expert Opinion on Orphan Drugs, Vol. 5, Núm. 2, pp. 181-192

  5. Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain

    PLoS ONE, Vol. 12, Núm. 2

  6. Factors associated with 30-day mortality in elderly inpatients with community acquired pneumonia during 2 influenza seasons

    Human Vaccines and Immunotherapeutics, Vol. 13, Núm. 2, pp. 450-455

  7. The effectiveness of influenza vaccination in preventing hospitalisations of elderly individuals in two influenza seasons: A multicentre case–control study, Spain, 2013/14 and 2014/15

    Eurosurveillance, Vol. 22, Núm. 34

2016

  1. Factors associated with influenza vaccination of hospitalized elderly patients in Spain

    PLoS ONE, Vol. 11, Núm. 1